H-Leu-alphaNA

H-Leu-alphaNA is an N-terminally protected leucine derivative in which the amino acid stereocenter is retained as L-leucine and the side chain presents the characteristic isobutyl group for hydrophobic peptide recognition. The structure contains a free carboxylate equivalent associated with the alphaNA functionality and an anilide-like/amide-type motif that can participate in coupling chemistry or serve as a masked reactive handle depending on the alphaNA form. The N-protection at the amino terminus supports controlled peptide bond formation while limiting undesired side reactions during stepwise synthesis. The combination of a chiral amino acid backbone with a functionalized carboxyl-related group makes H-Leu-alphaNA suitable as a chiral intermediate for downstream amino acid derivatization and peptide building block preparation.

1. Peptide Synthesis

H-Leu-alphaNA is applied in peptide synthesis workflows where an N-protected leucine unit is required for stepwise amide bond construction. The leucine backbone provides a stereodefined chiral center, while the side-chain isobutyl group supports incorporation into hydrophobic peptide segments and peptidomimetic scaffolds. The alphaNA functionality can function as a protected carboxyl-related component that participates in coupling chemistry under standard peptide synthesis conditions, enabling controlled formation of C-terminal linkages. The resulting leucine-containing intermediates can be carried into sequential coupling cycles to generate longer peptides with defined N-terminus and side-chain context, supporting research-grade peptide library assembly and synthetic methodology development.

2. Unnatural Amino Acid Incorporation

H-Leu-alphaNA is suitable for chemical biology and medicinal chemistry programs that require precise incorporation of leucine analogs or chiral building blocks into peptide-like structures. The maintained L-configuration at the alpha carbon supports stereochemical fidelity for structure-dependent binding studies and for generating well-defined stereochemical controls in analog series. The N-protected amino terminus and the functionalized carboxyl-related group enable orthogonal derivatization strategies, including selective deprotection or activation to install the compound into larger frameworks. Downstream use can include preparing stereochemically defined peptide conjugates or peptidomimetic fragments used in molecular design campaigns and SAR studies.

3. Chemical Biology Probes

H-Leu-alphaNA can be employed in chemical biology research where leucine-based fragments are used as handles for probe construction and biomolecular modification. The hydrophobic leucine side chain can aid in positioning within peptide substrates, affinity reagents, or recognition elements, while the protected amino group supports sequential functionalization without premature cross-reaction. The alphaNA-related functionality can serve as a synthetic intermediate for introducing additional reactive groups, such as electrophilic or conjugatable motifs, into peptide-derived probes. The resulting labeled or derivatized molecules can be used for studying biomolecular interactions, mapping binding determinants, or generating defined standards for analytical investigations.

4. Process Chemistry Intermediate

H-Leu-alphaNA serves as a chiral amino acid intermediate in process chemistry and fine chemical synthesis where controlled protection and activation are required for scalable peptide building block manufacture. The N-terminal protection reduces side reactions during handling and coupling steps, while the stable chiral leucine framework supports reproducible stereochemical outcomes across batch synthesis. The alphaNA functionality provides a defined reactive site for downstream transformation into activated carboxyl derivatives or coupling-ready forms, supporting manufacturing route design that minimizes purification burden between steps. The compound can be integrated into industrial workflows for producing leucine-containing intermediates used in peptide manufacturing, peptide analog production, and specialty chemical production.

5. Analytical Standards Development

H-Leu-alphaNA is suitable for analytical research and method development where chiral amino acid derivatives are needed as reference materials. The combination of a protected amino terminus and a defined leucine stereocenter supports unambiguous chromatographic and spectrometric characterization relative to structurally related analogs. The alphaNA-associated functional group can provide characteristic fragmentation or retention behavior, enabling reliable identification of leucine-derived intermediates during peptide synthesis monitoring. Downstream formation of related derivatives from this compound can also support calibration standards for impurity profiling, stereochemical verification, and process-related analytical method validation in amino acid and peptide manufacturing contexts.

1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

3. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

4. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes